企業プロフィール
Centogene 株価・ニュース・カタリスト
- ティッカー:
- CNTG
- 取引所:
- NASDAQ
- セクター:
- MedTech
- 所在地:
- Germany and has traded publicly in the U
株価変動の要因
Current closing-price context is not available for CNTG.
企業概要
事業概要
Centogene is a precision medicine and rare-disease diagnostics company that combines testing, data, and patient identification. Its business sits at the intersection of diagnostics, genetics, and rare-disease discovery.
所在地とセクター分類
Centogene is headquartered in Germany and has traded publicly in the U.S. market, giving it a global diagnostics profile. It is more of a rare-disease information company than a therapeutics developer.
ビジネスモデルの特徴
The model depends on test utilization, data services, and partnerships with life-science customers and physicians. Investors usually focus on diagnostic demand, international reach, and whether the company can turn rare-disease insight into recurring revenue.
バイオ業界での位置付け
Centogene occupies a diagnostics-and-data niche inside the broader biotech ecosystem. It is not a drug stock, but it is relevant because rare-disease identification and genomic testing support the development pathway.
今後のカタリスト
- Centogene’s catalysts are rare-disease diagnostics demand and any commercial or strategic update that clarifies the company’s future. The business is still about whether the platform can find a durable footprint.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。